Cold Spring Harbor Laboratory Office of Technology Transfer Patents Licensing Intellectual Property IP DNA RNAi biotechnology James Watson Francis Crick MTA

Cancer

Hannon04-Compositions and methods of cancer diagnosis and treatment

Lazebnik01-Oncogene-induced apoptosis in drug-resistant cells

Lazebnik03-Methods for treating cancer

Lowe01-Enhancement of drug cytotoxicity in tumor cells containing mutant Rb gene

Lowe02-Lymphoma-susceptible transgenic mice and methods for studying drug sensitivity of lymphomas

Lowe04-Model for studying the role of genes in tumor resistance to chemotherapy

Lowe05-p53determines in vivo response to targeted therapy in human CML

Lowe06-Orthotopic, controllable and genetically tractable non-human animal model for cancer

Lowe07-A research tool for RNAi: A reversible and regulated RNAi expression system

Lowe08-Identification of genetic alterations that modulate drug sensitivity in cancer treatments

Mills01-Chd5 is a novel tumor suppressor gene

Mittal03-Treatment of tumors by abating bone marrow-derived endothelial progenitor cells

[Office of Technology Transfer] [Licensing] [Cancer] [RNAi] [Neuroscience] [Plant Science] [Malaria] [Vectors] [Auditory Aids] [Antibody] [Technologies] [RNAi] [MTA] [Software] [Start-Ups] [Resources] [News] [About Us] [Contact Us]

© 2005 Cold Spring Harbor Laboratory